The Paris techbio company screens microbial genomes to find molecules that evolution spent three billion years producing, and claims to have characterised more novel small molecules in 2025 than the rest of the field combined. Alven and Daphni co-led the Series A. Generare, the Paris-based techbio company reading microbial genomes for molecules that drug development […]<br /> This story continues at The Next Web [...]
Nvidia’s $20 billion strategic licensing deal with Groq represents one of the first clear moves in a four-front fight over the future AI stack. 2026 is when that fight becomes obvious to enterprise [...]
The startup, which plants millions of decoy assets across cloud environments to catch intruders in the act, closed its Series A led by FirstMark as enterprise security teams warm to deception as a pri [...]
Theom, the company redefining data governance and security for the AI era, announced today it has raised $20 million in Series A funding to accelerate its mission of securing sensitive enterprise data [...]
For more than three decades, modern CPUs have relied on speculative execution to keep pipelines full. When it emerged in the 1990s, speculation was hailed as a breakthrough — just as pipelining and [...]
Every patient discharge in a European hospital triggers a paperwork cascade. Clinical information from the stay must be converted into standardised codes, the ICD classifications and procedure codes t [...]
The Copenhagen fintech has built a platform of specialised AI agents that handle KYC and KYB work, document reviews, ownership mapping, risk rationale, in minutes rather than hours. NEA led the Series [...]
Australian-German startup Quantum Brilliance has raised $20mn in Series A funding as it looks to deploy small, portable quantum accelerators that promise to supercharge the computational power of ever [...]